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Abstract
Human noroviruses (HuNoV), a major cause of acute gastroenteritis worldwide, cannot be readily cultured in the lab.
Therefore, a feline calicivirus (FCV) is often used as its surrogate to, among other things, test alcohol-based handrubs
(ABHR). The more recent laboratory culture of a mouse norovirus (MNV) provides an alternative. While MNV is closer to
HuNoV in several respects, to date, no comparative testing of FCV and MNV survival and inactivation on human hands has
been performed. This study was designed to address the knowledge gap. The rates of loss in viability during drying on
hands were 21.91 and 21.65% per minute for FCV and MNV, respectively. When the contaminated skin was exposed for
20 s to either a commercial ABHR with 62% (v/v) ethanol or to 75% (v/v) ethanol in water, FCV infectivity was reduced by ,1
log10 while that of MNV by nearly 2.8 log10. Extending the contact time to 30 s reduced the FCV titer by almost 2 log10 by
both test substances and that of MNV by .3.5 log10 by the commercial ABHR while 75% ethanol did not show any
noticeable improvement in activity as compared to the 20 s contact. An 80% (v/v) aqueous solution of ethanol gave only a
1.75 log10 reduction in MNV activity after 20 s. The results show significant differences in the ethanol susceptibility of FCV
and MNV in contact times relevant to field use of ABHR and also that 62% ethanol was a more effective virucide than either
75% or 80% ethanol. These findings indicate the need for a review of the continuing use of FCV as a surrogate for HuNoV.
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Introduction
Human noroviruses (HuNoV) remain the most common cause
of acute viral gastroenteritis (AVG) with 6 million clinical cases
and 200,000 deaths/year worldwide [1]. Outbreaks of HuNoV are
frequent in healthcare [2], community settings [3] and onboard
cruise ships [4]; nosocomial outbreaks can close hospital wards [5].
The virus is shed in feces and in vomitus [6] and is relatively stable
outside hosts [7,8].
Since laboratory culture of HuNoV is difficult, the feline
calicivirus (FCV) is often used as its surrogate in testing, among
other things, microbicides [9,10]. However, FCV may be
unsuitable for this purpose due its higher acid sensitivity and also
because it is normally a respiratory pathogen in felines [11].
The successful in vitro culture of a murine norovirus (MNV) now
provides an alternative to FCV [12]; MNV is similar in acid
resistance to HuNoV and also causes in mice a disease highly
reminiscent of AVG in humans [12]. These factors, and a closer
genetic kinship to HuNoV, could make MNV a better surrogate for
testing microbicides, including alcohol-based handrubs (ABHR).
Comparative studies between MNV and FCV have been
published; however, they have focused either on the environmental
survival of the viruses [11,13] or compared the activity of chemicals
against FCV and MNV in in vitro settings [14–16]. There has been
no documented comparison of the activity of ethanol and ethanol-
based ABHR against FCV and MNV using an in vivo test protocol.
The information gained from such a comparison would allow for a
better understanding of the choice of surrogate for HuNoV. This
study was designed to fill the knowledge gap.
Materials and Methods
ABHR tested
The concentrations of ethanol used are given as volume/volume
(v/v). The ABHR tested were one commercial gel with 62%
ethanol as the only listed active, and aqueous ethanol solutions at
75% and 80%.
Subjects
This study was approved by the Ottawa Hospital Research Ethics
Board (OHREB) under protocol #2000289-01H: The use of
Fingerpads of Adult Volunteers to Investigate the Germicidal Activity
of Handwash and Handrub Agents. Persons (20–60 years in age),
were briefed on the project and those willing to participate gave signed
consent. Each subject then received microbicide-free personal care
items for use starting a one week before the first day of participation in
the study. Six subjects were used in each comparative test.
Viruses
Strain F9 of FCV (ATCC #VR-782) was received from Dr. S.
Bidawid (Health Canada, Ottawa, ON) and MNV Type 1 was a
gift from Dr. H.W. Virgin (Washington Univ., St. Louis, MO).
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CrFK cells (ATCC CCL-94) and RAW 267.4 cells (ATCC
#TIB-71) were also obtained from Dr. Bidawid and were used to
grow and plaque assay FCV and MNV, respectively.
Preparation of virus pools
Monolayers of both types of cells were grown at 3661uCi n
Eagle’s minimal essential medium (MEM; Invitrogen, Burlington,
ON, Canada) with 10% fetal bovine serum (FBS; Invitrogen
Burlington, ON, Canada), 2% L-Glutamine (Invitrogen), and 2%
of 7.5% sodium bicarbonate (NaHCO3.7H2O) in 75 cm
2 plastic
flasks (Sarstedt, Saint-Leonard, QC, Canada).
Each monolayer separately received 200 mL of FCV or MNV
and the flasks were held for one h at 3661uC for virus adsorption.
Ten mL of MEM supplemented with 2% FBS was added to each
flask and reincubated at 3661uC till nearly 80% of each
monolayer showed virus-induced cytopathology. The flasks were
then subjected to three freeze-thaw cycles for virus release, their
contents centrifuged at 1,0006g for ten minutes and the
supernatant was pooled and then aliquoted for storage at 280uC.
Soil load
All virus inocula contained a soil load to simulate the presence
of feces or vomitus. A 340-ml volume of virus suspension was
mixed with 35 ml 5% Tryptone (BD Difco; Mississauga, ON,
Canada), 25 ml of 5% bovine serum albumin (BD Difco;
Mississauga, ON, Canada), and 100 ml of 0.4% mucin (type 1)
from bovine submaxillary glands (Sigma, St. Louis, MO), all in
sterile normal saline in phosphate buffer (pH 7.2) with a total
protein content roughly equal to that in 5% FBS [17]. The final
concentration of the virus was approximately 10
7 plaque-forming
units (PFU)/mL.
Plaque assays
The plaque assay methods for FCV and MNV were as described
previously by Wobus et al. [18] and Bidawid et al [12], respectively.
Briefly, host cell monolayers were prepared in 12-well cluster plates
(Corning; Fisher, Ottawa, ON,Canada)in2 mL ofgrowth medium
(supplemented MEM with 10% FBS) in each well and incubated at
3661uC in a 5% CO2 atmosphere for 16–18 h. The medium was
aspiratedand 0.1 mLofthevirussampledilutedinEarle’sBalanced
Salt Solution (EBSS; Invitrogen) was placed separately in each of at
least three wells. Each plate also included two wells as negative
controls (0.1 mL EBSS only) and one well as positive control
(0.1 mL of undiluted virus). The inoculated plates were incubated
one h for virus adsorption. Each well then received 2 mL of an agar
overlay and reincubated for plaque formation for 18 and 36 hours
for FCV and MNV, respectively. The monolayers were then fixed
and stained for PFU as described [18].
Inoculating fingerpads
The subject’s hands were first inspected to ensure freedom from
any apparent damage. The subject then removed all ornaments
from the hands and forearms and washed the hands with a non-
medicated soap, rinsed them with running tap water (,40uC) and
dried them with a paper towel. Five mL of 70% ethanol was put
into the subject’s cupped hands for rubbing over both hands till
dry. The pad of each digit was pressed against the mouth of an
empty 2.0 mL cryovial (Sarstedt, St. Leonard, QC, Canada) for a
circular indentation to place the inoculum at its centre. The
subject then sat with the hands inside a laminar-flow hood to
receive the virus. A virus inoculum of 10 ml was placed on each
fingerpad using a positive-displacement pipette.
The air temperature and relatively humidity in the lab during the
experiments ranged between 22–26uC and 45–55%, respectively.
Virus elution
The digit to be eluted was placed over the mouth of a cryovial
containing 1 mL of the eluent consisting of EBSS supplemented
with 0.1% Tween-80 (Sigma-Aldrich, Oakville, ON, Canada),
which neutralized the test solution through dilution and
disaggregated viral clumps to provide a more realistic assessment
of inactivation. The vial was inverted with the digit still in place
and the eluent brought into contact with the contaminated area
for 10 seconds followed by 20 full inversions. The 10-second
contact and the inversion steps were performed once more. The
vial was then turned upright and the surface of the skin was firmly
scraped against the inside rim of the vial in a downward motion.
Each fingerpad was inspected to ensure that the skin was free of
any visible liquid. The skin of each pad was decontaminated by
pressing it against a paper towel soaked in domestic bleach (1,000
ppm available chlorine) for 3 minutes. The subject then washed
both hands with plain soap and dried them thoroughly before
leaving the lab.
Testing virus survival
Both thumbpads received 10 mL of the test virus in soil load and
the inocula eluted immediately representing the ‘zero-time’ control
or the number of PFU placed on each digit. Each fingerpad then
received 10 mL of the virus and observed for drying. The inocula
were eluted from two randomly-selected fingerpads (one left and
one right) simultaneously after 20, 30 and 40 min.
Virucidal activity of test formulations and controls
This procedure was based on the standard #E-1838-10 of
ASTM International [17]. Briefly, both thumbpads received
10 mL of the test virus and the inoculum was eluted immediately
and simultaneously from both (see below) and the thumbpads
decontaminated; this represented the ‘zero-time’ control or the
number of PFU placed on each digit. Each fingerpad then
received 10 mL of virus and the subject kept the hands still in a
laminar flow hood with the blower on till the inocula were
visibly dry. Two randomly-selected fingerpads were eluted at this
stage for the ‘baseline value’ or the PFU that survived the
drying.
To test for virucidal activity, at least two randomly-selected
fingerpads (one from each hand) were exposed simultaneously to
1.0 mL of the test substance or control fluid in a 2-mL cryovial by
placing each fingerpad separately over the mouth of a vial and
inverting to bring the fluid into contact with the skin for the
required contact time. The fingerpad was then eluted as described
above but the liquid remaining on the skin was not scraped off.
The virus inoculation, drying, exposure and elution steps were
repeated for the remaining fingers. The fingerpads were
decontaminated with diluted bleach and washed as mentioned
above.
Data Analysis
For virus survival, regression analysis was performed to
determine a rate of decay for each virus. Rates of decay were
compared between viruses using a one-way Analysis of Co-
Variance (ANCOVA). For virus inactivation experiments, six
replicates were performed for each inactivation test and
statistically analyzed using the Analysis of Variance (ANOVA)
test with post-hoc Tukey Honestly Significant Difference (HSD)
analysis.
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Virus survival on hands
Survival of the viruses on the fingerpads was normalized to a
percentage survival to demonstrate the comparative decay in the
viability of the viruses. Three samples for each time point and each
virus were analyzed to ensure proper regression and ANCOVA
analysis could be performed. As shown in Figure 1, virus survival
was negatively associated with time. FCV viability was reduced at
a rate of 1.91 percent per minute (r
2=0.82). MNV reduction was
1.65 percent per minute (r
2=0.64). Using the one-way ANCOVA
test, the two rates of decay were not found to be significantly
different (F=0.61; p=0.44).
Inactivation of FCV and MNV by ethanol-based ABHR and
Ethanol
Six subjects for each concentration and contact time were used
to allow for proper statistical analyses. Fig. 2A and 2B show the
reduction in the viability of both viruses after 20 s and 30 s of
contact, respectively. At 20 s, both levels of ethanol produced a,1
log10 reduction in FCV infectivity, while the reductions in MNV
infectivity was almost 3 log10. Increasing the contact time to 30 s
enhanced the reduction in FCV infectivity to about 2 log10
irrespective of the ethanol concentration. Whereas there appeared
to be no significant difference between the activities of 62% and
75% ethanol against MNV at 20 s (Figure 2A), a difference was
noted between the activities of the two ethanol concentrations with
a contact time of 30 s (Figure 2B). However, the results of
ANOVA and Tukey analyses were inconclusive due to variations
in the data.
We thus compared the activities of three concentrations of
ethanol against MNV at a contact time of 20 seconds. The results
(Fig. 3) showed 62% ethanol was better than 75% ethanol (p,0.01
ANOVA; p,0.01 Tukey HSD) and that both concentrations
showed better activity than the 80% solution (p,0.01 ANOVA;
p,0.01 Tukey HSD).
Discussion
This is the first report on comparative testing of the survival on
skin and ethanol resistance of the two leading surrogates for
HuNoV under conditions that closely mimic actual field use.
Our findings suggest that, the ability of the two viruses to survive
on the hands of adults over the normal drying time [19]) was not
significantly different. However, the time-associated reduction did
demonstrate the necessity to perform reduction calculations using
the baseline value (i.e. dried virus) as the starting point rather than
the zero time.
The commercial product chosen claimed only one active
ingredient, ethanol, with no other antimicrobial activity from the
excipients. Other commercial products with higher concentrations
of alcohol were found to be a mixture of ethanol and isopropanol,
which was outside the scope of this study. Moreover, several
formulations contained other excipients such as organic acids,
which could bias the study and thus were not included. The choice
of an aqueous ethanol solution was to ensure that only ethanol was
the active to be tested. It should be noted here that non-alcohol-
based formulations usually also are aqueous with only one active
ingredient. However, the actives are often a quaternary-ammoni-
um compounds (quats), which are weak in their activity against
non-enveloped viruses in particular.
There have been several studies focusing on the resistance of FCV
or MNV to various alcohol solutions [10,20,21]. However, there has
been little consistency between the methods, the test materials, the
viral challenge and the contact time. This has unfortunately led to
confusion with respect to the use of ABHR and a plethora of
comments and claims of activity that may not be entirely accurate for
field use. The in vivo method used in this study is a standard of ASTM
International [17] and it is recommended by the World Health
Organization [22] for testing ABHR against human pathogenic
viruses. It has been used previously for studies focusing on the in vivo
evaluation of virucidal activity of antiseptics [19,23–25]. The test
gives data comparable to that with the whole-hand method [19,24],
while permitting a more thorough inspection of the hands of the
Figure 1. Survival of FCV ( ) and MNV (&) on human skin. Ten mL of virus in soil load was placed on the fingerpads of volunteers and allowed
to dry. After 20, 30 or 40 minutes, the virus was eluted off the fingerpads and enumerated using plaque assays. Lines of decay were calculated using
regression analysis and determined to be 1.91 percent per minute for FCV (r
2=0.82) and 1.65 percent per minute for MNV (r
2=0.64). Analysis of
Co-Variance (ANCOVA) testing of the two regression lines demonstrated no significant difference between the two viruses (F=0.61; p=0.44).
doi:10.1371/journal.pone.0017340.g001
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nation virtually risk-free. Further, much smaller volumes of virus
pools are required for the fingerpad method while allowing for
replicates and controls being tested on the same subject in any given
sitting. Perhaps the most useful aspect of this test is the ability to
control the contact time precisely. In this study, contact times were at
their lowest 20 seconds, which is perhaps the shortest time tested yet
may be the most accurately representative of field use [20].
Since ABHR are no-rinse formulations, they are expected to
inactivate pathogens in situ to achieve hand antisepsis. In view of
this, the test substance remaining on the fingerpads at the end of
the contact time was not scraped off but allowed to remain there
for subsequent elution to better represent field use.
Even though ABHR are meant for use on hands free of visible
contamination, a certain level of soiling of hands is inevitable
during casual contact with the environment. The soil load added
to the virus inocula was to represent this low level of organic and
inorganic contamination on the skin, the potential protection it
could afford to handborne pathogens and the ability of the tested
formulations to achieve virus inactivation in its presence.
The observed differences between the susceptibilities of the two
viruses to ABHR in general may be due to the structural properties
Figure 2. Reduction in the viability of FCV and MNV after contact with ethanol. Virus reduction was observed after 20 s (A) or 30 s (B)
contact time with a commercial ABHR (62% ethanol) and an aqueous solution of 75% (v/v) ethanol on the fingerpads of adult subjects (n=6).
Significant difference between FCV and MNV (p,0.01) indicated by asterisks.
doi:10.1371/journal.pone.0017340.g002
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destabilize water and hydrophilic amino acids [26]. The cell
receptor binding motif of FCV consists of a hypervariable region
with mainly hydrophobic, neutral residues [27]. The effect of
ethanol concentration, therefore, would be minimal on the active
site yet, over time, general capsid instability would occur, leading
to inactivation. The findings of this study correlate well with those
of Kampf et al. who showed no significant difference in FCV
virucidal activity with varying concentrations of ethanol between
75 and 95% [9]. In contrast to FCV, the cell receptor binding
motif of MNV consists of numerous hydrophilic residues, which
would be affected by concentrations of ethanol $45%. In this
study, the 62% ABHR reduced the MNV titre by nearly 2.5 log10
(99.7%) in as little as 15 seconds and by 20 seconds, the titre was
reduced by over 3.0 log10 (.99.9%).
Of particular note is the lowering of virucidal activity with the
increase in ethanol concentration (Fig. 2 & 3). Parke and Birch
[28] investigated various concentrations of ethanol and found that
optimal destabilization of water molecules (and thus hydrophilic
amino acid residues) did not positively correlate with higher
ethanol concentrations but peaked at or near 62% ethanol and
lessened exponentially as the concentration increased. Thus, the
effect of 75% or 80% ethanol would be significantly less than that
of 62% ethanol at shorter periods of time. The data presented here
follows with that of Gehrke et al [21] who demonstrated a similar
difference of efficacy between 62% and higher concentrations of
ethanol (as well as 1- and 2-propanol) with longer contact times of
0.5 and 1.0 minutes.
One limitation of this study was that the 62%-ethanol-based test
substance was a commercial ABHR while the 75% and 80%
solutions were non-commercial. However, as discussed above, the
presented data focused on ethanol alone as the active ingredient
and thus should not be extrapolated to other formulations that
contain isopropanol, organic acids or other residual antimicrobial
agents. That being stated, the dramatic difference in efficacy as it
relates to contact time (Fig. 3) should not be overlooked.
The comparative data presented here using a standardized in
vivo test protocol shows that MNV, a virus much closer to HuNoV
in several respects, is more readily inactivated by ABHR in
relatively short contact times. This suggests the need for a wider
acceptance of MNV as a surrogate for HuNoV and eventual
phase-out of FCV for the purpose. Health Canada’s recent
guidance document on human-use antiseptic drugs now recom-
mends the use of MNV as a surrogate for HuNoV to generate data
for product registration [29]. Any further discussion of the topic of
surrogates in this regard should wait till one is able to routinely
culture and assay the infectivity of HuNoV in vitro. Such a change
may also help reverse the impression in the minds of many
infection preventionists that ABHR are ineffective in dealing with
HuNoV outbreaks, based on the available data using FCV as its
surrogate.
This comparative in vivo study showed that at shorter contact
times, MNV is less resistant to ethanol-based ABHR than FCV.
Extending the contact time reduced the difference between the
two viruses with 75% ethanol but not with 62% ethanol. These
differences may be a result of the various physicochemical
characteristics of FCV and MNV but that ethanol concentration
and contact time do play a significant role in the performance of
an ethanol-based ABHR.
Author Contributions
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Figure 3. Reduction of MNV after 20 second contact with ethanol. MNV reduction was observed after 20 s contact time with one of either a
commercial ABHR (62% ethanol), 75% ethanol or 80% aqueous ethanol solution on the fingerpads of adult subjects (n=6). Significant differences
were observed between both 62% and 75% (p,0.01) and 80% (p,0.01) indicated by asterisks (*). A significant difference was also seen between 75%
and 80% (p,0.01) indicated by the double dagger ({).
doi:10.1371/journal.pone.0017340.g003
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